GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a substantial innovation in how we treat type 2 diabetes . These prescription drugs help mimicking Joulabs the body’s inherent GLP-1 substance , which promotes glucose regulation and lowers blood sugar production . Beyond b